What screening tests are recommended for a woman of reproductive age with regular menstrual cycles and plans for pregnancy, presenting with breast tenderness and no abnormal breast examination findings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Screening Test: Papanicolaou Smear

This woman of reproductive age planning pregnancy within 2 years should undergo Papanicolaou (Pap) smear screening, making option B the correct answer. Her breast tenderness is a normal physiologic finding that does not warrant imaging in the absence of abnormal clinical examination findings.

Cervical Cancer Screening Rationale

Pap smear screening is indicated for this patient based on standard cervical cancer screening guidelines:

  • Women should begin Pap testing approximately 3 years after becoming sexually active, but no later than age 21 1
  • For women using conventional Pap tests, screening should occur annually 1
  • For women using liquid-based Pap tests, screening intervals can be every 2 years 1
  • Pregnancy provides an excellent opportunity to screen women who may not otherwise seek routine gynecologic care 2
  • Pap testing during pregnancy is safe, necessary, and acceptable as a routine prenatal test 3

Why Breast Imaging Is NOT Indicated

The breast tenderness described is physiologic cyclical mastopathy, not a pathologic finding requiring imaging:

  • Cyclical breast tenderness beginning 3 days before menses is a normal premenstrual symptom, not an indication for screening 4, 5
  • Clinical breast examination showed bilateral symmetry with no palpable abnormalities 1
  • Breast ultrasound (Option A) is not indicated for normal cyclical breast tenderness without a palpable mass or other concerning findings 6
  • Mammographic screening begins at age 40 for average-risk women 1
  • Between ages 20-39, clinical breast examination every 3 years is sufficient for average-risk women 1

Why Other Options Are Incorrect

HPV testing (Option C) is not the primary screening modality:

  • HPV testing may be used in conjunction with Pap testing beginning at age 30, but Pap smear remains the primary screening test 1
  • For women under 30, Pap testing alone is the standard approach 1

Group B Streptococcus screening (Option D) is premature:

  • GBS screening is performed at 35-37 weeks gestation in pregnant women, not during preconception planning 1
  • This patient is not yet pregnant and plans pregnancy within 2 years 1

Clinical Pearls

  • Normal cyclical breast tenderness affects many reproductive-age women and peaks premenstrually 5
  • The absence of family history of cancer and normal breast examination findings further support that breast imaging is unnecessary 1
  • Routine prenatal care provides an opportunity to address cervical cancer screening in women who may have delayed preventive care 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Caring for women with abnormal papanicolaou tests during pregnancy.

Journal of midwifery & women's health, 2009

Research

[Papanicolaou test in pregnancy].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2000

Guideline

Management of Severe Focal Breast Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.